CMO Supplier Quality Agreements - How to Comply with New FDA and EU Guidelines for Contract Drug Manufacture

Event Information
Product Format
Prerecorded Event
Conference Date
Thu, Jan 19, 2017
60 minutes
Product Description

GMP Compliance and New FDA and EU Guidelines for Contract Drug Manufacturing

A contract between a GMP Contract Manufacturer and a pharmaceutical firm is a Quality Agreement and it details responsibilities of both parties by assuring the safety, efficacy and quality of the drug that has been manufactured. Recently FDA and the EU issued regulatory guidance which aims in bringing out some consistency as well as clarity to some quality contracts such as:

  • EU GMP Chapter 7 "Outsourced Activities" (Revised)
  • Draft Guidance for Industry - "Contract Manufacturing Arrangements for Drugs: Quality Agreements" May 2013

The global contract manufacturing organization (CMO) market in 2010 was estimated to be at $26 billion, increasing by 10.7% since 2008. This increased outsourcing in the pharma industry as well as recent quality issues with CMOs that have been well publicized, has brought out the importance and need for having an excellent quality oversight into external manufacturers so that GMP compliance is assured. Quality Agreement will be used as a tool to accomplish this objective.

To control CMOs and other such suppliers has always been a requirement of FDA and EU. Issuing these new regulatory documentations has fueled an exception that this control will have written documentation and proof of the control can be presented to EU/FDA inspectors as Quality Agreements specific to particular CMO.

This session by expert speaker Roger Cowan is aimed at providing a clear understanding of the content expected in Quality Agreements from a regulatory perspective. Roger will fully analyze each section of the proposed Quality Agreement suggest appropriate content each while taking into consideration the new guidelines. The webinar will also provide a comparison of both the regulatory documents, and highlight and discuss the differences.

Roger will get into the details of quality agreement, including change control, documentation, facilities and equipment, lab controls, sub-contracting, etc. Lastly, he will provide insight on the latest status of FDA draft guidance and review comments from the industry.

Session Highlights:

  • The Who and What of a good Quality Agreement
  • What a Quality Agreement is and isn’t?
  • Responsibilities of the owner vs. contract facility
  • GMP responsibilities
  • A comparison of the new guidelines from the FDA and the EU

Who Should Attend

  • Quality Assurance
  • External Manufacturing / Outsourcing
  • Quality Auditing
  • Technology Transfer
  • Regulatory Affairs / Compliance
  • Supply Chain
  • Purchasing
  • Risk Management

Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.

Order Below or Call 1-866-458-2965 Today

You can also order through:




About Our Speaker

Roger Cowan - Pharmaceutical Contract Manufacturing

Roger Cowan is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 37 years’ experience in pharmaceutical quality assurance and manufacturing. In his career, Roger has held various manager / director positions in Quality Assurance, QC Laboratory, Technical Services Validation, Manufacturing, and Clinical Supply manufacturing and distribution. Roger has taught courses in microbiology...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus